Citigroup Inc. boosted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 143.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 59,448 shares of the health services provider's stock after purchasing an additional 35,012 shares during the quarter. Citigroup Inc. owned approximately 0.10% of Maximus worth $5,538,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its holdings in shares of Maximus by 7.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider's stock valued at $98,904,000 after purchasing an additional 79,092 shares during the last quarter. Van Berkom & Associates Inc. boosted its holdings in Maximus by 0.8% in the second quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider's stock valued at $98,257,000 after acquiring an additional 8,811 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock valued at $86,552,000 after acquiring an additional 102,350 shares during the last quarter. Assenagon Asset Management S.A. grew its position in Maximus by 277.0% during the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider's stock valued at $81,878,000 after acquiring an additional 645,760 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its stake in Maximus by 1.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 705,400 shares of the health services provider's stock worth $65,715,000 after acquiring an additional 8,667 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Maximus
In other Maximus news, insider Michelle F. Link sold 1,363 shares of the business's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at approximately $607,841.52. The trade was a 17.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.40% of the stock is currently owned by insiders.
Maximus Stock Down 0.5 %
Shares of NYSE MMS traded down $0.34 on Monday, hitting $74.16. The company had a trading volume of 1,021,220 shares, compared to its average volume of 412,113. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 12-month low of $71.75 and a 12-month high of $93.97. The firm has a market capitalization of $4.47 billion, a P/E ratio of 14.83 and a beta of 0.77. The business has a 50 day moving average of $86.50 and a two-hundred day moving average of $87.58.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Friday, November 15th. Maximus's dividend payout ratio (DPR) is currently 24.00%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday.
View Our Latest Report on MMS
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.